↓ Skip to main content

Thrombosis and Embolism: from Research to Clinical Practice

Overview of attention for book
Cover of 'Thrombosis and Embolism: from Research to Clinical Practice'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 100 The Prevention of Venous Thromboembolism in Surgical Patients
  3. Altmetric Badge
    Chapter 101 Thromboembolic Prophylaxis for Morbidly Obese Patients Undergoing Bariatric Surgery
  4. Altmetric Badge
    Chapter 102 The Use of Surgical Care Improvement Projects in Prevention of Venous Thromboembolism
  5. Altmetric Badge
    Chapter 103 The Diagnosis and Management of Early Deep Vein Thrombosis
  6. Altmetric Badge
    Chapter 104 Symptomatology, Clinical Presentation and Basic Work up in Patients with Suspected Pulmonary Embolism
  7. Altmetric Badge
    Chapter 105 Radionuclide Diagnosis of Pulmonary Embolism
  8. Altmetric Badge
    Chapter 106 Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism
  9. Altmetric Badge
    Chapter 107 Surgical Treatment of Acute Massive Pulmonary Embolism
  10. Altmetric Badge
    Chapter 108 The Optimal Duration of Anticoagulation in Patients with Unprovoked Venous Thromboembolism
  11. Altmetric Badge
    Chapter 109 Anticoagulation Therapy in Patients with Chronic Kidney Disease
  12. Altmetric Badge
    Chapter 110 Cancer-Associated Thrombosis: Regulatory Mechanisms and Emerging Directions
  13. Altmetric Badge
    Chapter 111 The Treatment of Venous Thromboembolism in Patients with Cancer
  14. Altmetric Badge
    Chapter 112 The Role of New Oral Anticoagulants (NOACs) in Cancer Patients
  15. Altmetric Badge
    Chapter 113 Venous Thromboembolic Disease in Children and Adolescents
  16. Altmetric Badge
    Chapter 114 Deep Vein Thrombosis in Intensive Care
  17. Altmetric Badge
    Chapter 115 Cerebral Venous Thrombosis
  18. Altmetric Badge
    Chapter 116 Endovascular Treatment of Thrombosis and Embolism
  19. Altmetric Badge
    Chapter 117 Venous Thromboembolism in Brain Tumor Patients
  20. Altmetric Badge
    Chapter 118 Portal Vein Thrombosis: Recent Advance
  21. Altmetric Badge
    Chapter 119 Portal Vein Thrombosis After Splenic and Pancreatic Surgery
  22. Altmetric Badge
    Chapter 120 Genetic Risk Factors in Venous Thromboembolism
  23. Altmetric Badge
    Chapter 121 Venous and Arterial Thrombosis: Is There a Link?
  24. Altmetric Badge
    Chapter 122 Thrombosis and von Willebrand Factor
  25. Altmetric Badge
    Chapter 123 Role of P2Y12 Receptor in Thrombosis
  26. Altmetric Badge
    Chapter 124 Proton Pump Inhibitors in Cardiovascular Disease: Drug Interactions with Antiplatelet Drugs
  27. Altmetric Badge
    Chapter 125 The Risk of Thromboembolism in Users of Antidepressants and Antipsychotics
  28. Altmetric Badge
    Chapter 126 Post Thrombotic Syndrome
  29. Altmetric Badge
    Chapter 128 A Review of the Evidence to Support Neuromuscular Electrical Stimulation in the Prevention and Management of Venous Disease
  30. Altmetric Badge
    Chapter 129 Non-Invasive Management of Peripheral Arterial Disease
  31. Altmetric Badge
    Chapter 130 Medico-Legal Aspects of Pulmonary Thromboembolism
Attention for Chapter 125: The Risk of Thromboembolism in Users of Antidepressants and Antipsychotics
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
The Risk of Thromboembolism in Users of Antidepressants and Antipsychotics
Chapter number 125
Book title
Thrombosis and Embolism: from Research to Clinical Practice
Published in
Advances in experimental medicine and biology, September 2016
DOI 10.1007/5584_2016_125
Pubmed ID
Book ISBNs
978-3-31-922107-6, 978-3-31-922108-3
Authors

Adelborg, Kasper, Sundbøll, Jens, Videbech, Poul, Grove, Erik L, Kasper Adelborg, Jens Sundbøll, Poul Videbech, Erik L. Grove M.D., Ph.D, FESC, Erik L. Grove

Editors

Md. Shahidul Islam

Abstract

Arterial and venous thromboembolism are common causes of morbidity and mortality in the Western world. Mental disorders are also highly prevalent with a lifetime risk of experiencing any psychiatric disease ranging between 32 % and 37 %. Depression and schizophrenia may increase the risk of thromboembolism through genetic, behavioral, and biological mechanisms. Treatment of psychiatric patients with psychotropic drugs is imperative to improve quality of life and to reduce morbidity and mortality. However, studies have shown that psychotropic drugs themselves may modify the risk of arterial and venous thromboembolism, which should be taken into consideration when using these drugs in clinical practice. This association is, however, multifactorial, complex and susceptible to several confounding factors. Psychotropic drugs are widely prescribed, also among patients with cardiovascular disease. Therefore, understanding the association with thromboembolism and the underlying pathophysiological mechanisms is of major importance and will be reviewed in this chapter.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 30%
Researcher 4 10%
Student > Master 3 8%
Other 2 5%
Professor 2 5%
Other 6 15%
Unknown 11 28%
Readers by discipline Count As %
Medicine and Dentistry 16 40%
Nursing and Health Professions 5 13%
Psychology 4 10%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Social Sciences 1 3%
Other 0 0%
Unknown 12 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 September 2016.
All research outputs
#20,341,859
of 22,888,307 outputs
Outputs from Advances in experimental medicine and biology
#3,973
of 4,952 outputs
Outputs of similar age
#278,390
of 320,716 outputs
Outputs of similar age from Advances in experimental medicine and biology
#77
of 97 outputs
Altmetric has tracked 22,888,307 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,952 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,716 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.